Table 3.

Correlation of ARID1a, BRG1 and BRM1 expression with molecular tumor data

		ARID1a expression					BRG1 expression					BRM expression
		Negative		Positive			Negative		Positive			Negative		Positive
		No.	%	No.	%	p value	No.	%	No.	%	p value	No.	%	No.	%	p value
MET amplification	none	45	9.9%	408	90.1%	0.642	18	4.0%	433	96.0%	1.00	44	9.6%	414	90.4%	0.002
	amplified	2	14.3%	12	85.7%		0	0.0%	15	100.0%		6	40.0%	9	60.0%
C-myc amplification	none	44	10.5%	376	89.5%	0.099	17	4.0%	406	96.0%	0.709	45	10.5%	384	89.5%	0.491
	amplified	2	3.4%	56	96.6%		1	1.8%	56	98.2%		4	6.9%	54	93.1%
KRAS amplification	none	39	9.7%	364	90.3%	0.839	17	4.2%	384	95.8%	0.548	46	11.3%	360	88.7%	0.037
	amplified	7	8.0%	80	92.0%		2	2.2%	87	97.8%		4	4.3%	90	95.7%
GATA6 amplification	none	44	10.4%	381	89.6%	0.070	19	4.5%	405	95.5%	0.240	45	10.5%	384	89.5%	0.631
	amplified	1	2.1%	46	97.9%		0	0.0%	47	100.0%		6	12.2%	43
PIK3CA amplification	none	44	10.7%	368	89.3%	1.000	15	3.6%	400	96.4%	0.236	47	11.2%	371	88.8%	0.417
	amplified	2	8.3%	22	91.7%		2	8.3%	22	91.7%		3	12.5%	21	87.5%
ERBB2 amplification	none	33	10.7%	275	89.3%	0.596	13	4.2%	297	95.8%	0.381	35	11.3%	276	88.7%	1.000
	amplified	3	7.0%	40	93.0%		0	0.0%	43	100%		4	9.5%	38	90.5%
TP53 mutation	negative	16	10.5%	136	89.5%	0.594	7	4.6%	146	95.4%	0.410	19	12.8%	130	87.2%	0.304
	mutated	19	8.9%	195	91.1%		6	2.9%	200	97.1%		20	9.2%	197	90.8